Sex-based differences in gene expression in hippocampus following postnatal lead exposure

Toxicology and Applied Pharmacology

Volumn 256, Issue 2, 2011, Pages 179-190

  Schneider, J S ^a   Anderson, D W ^a   Sonnenahalli, H ^a   Vadigepalli, R ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Hippocampus; Lead; MRNA; Rat; Sex

Indexed keywords

LEAD;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; LEAD BLOOD LEVEL; LEAD POISONING; MALE; NONHUMAN; PERINATAL PERIOD; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE;

ANIMALS; ANIMALS, NEWBORN; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HIPPOCAMPUS; LEAD POISONING, NERVOUS SYSTEM; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, LONG-EVANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEX FACTORS;

RATTUS;

EID: 80053133109     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.08.008     Document Type: Article

References (88)

1. Anon. Managing Elevated Blood Lead Levels among Young Children: Recomendandations from the Advisory Committee on Childhood Lead Poisoning Prevention, Centers for Disease Control and Prevention (CDC) 2002.
2. Anon. A Review of the Evidence of Health Effects of Blood Lead Levels <10μg/Dl in Children. A Report by the Working Group of the Advisory Committee on Childhood Lead Poisoning Prevention, Centers for Disease Control and Prevention (CDC) 2004.
3. Alkondon M., Costa A.C., Radhakrishnan V., Aronstam R.S., Albuquerque E.X. Selective blockade of Nmda-activated channel currents may be implicated in learning deficits caused by lead. FEBS Lett. 1990, 261(1):124-130.
4. Andrus B.M., Blizinsky K., Vedell P.T., Dennis K., Shukla P.K., Schaffer D.J., Radulovic J., Churchill G.A., Redei E.E. Gene expression patterns in the hippocampus and amygdala of endogenous depression and chronic stress models. Mol. Psychiatry 2010, 1-13. 10.1038/mp. 2010.119.
5. Bellinger D., Leviton A., Sloman J. Antecedents and correlates of improved cognitive performance in children exposed in utero to low levels of lead. Environ. Health Perspect. 1990, 89:5-11.
6. Bendikov I., Nadri C., Amar S., Panizzutti R., De Miranda J., Wolosker H., Agam G. A CSF and postmortem brain study of d-serine metabolic parameters in schizophrenia. Schizophr. Res. 2007, 90(1-3):41-51.
7. Bergstrom A., Jayatissa M.N., Thykjaer T., Wiborg O. Molecular pathways associated with stress resilience and drug resistance in the chronic mild stress rat model of depression: a gene expression study. J. Mol. Neurosci. 2007, 33(2):201-215.
8. Biala Y.N., Bogoch Y., Bejar C., Linial M., Weinstock M. Prenatal stress diminishes gender differences in behavior and in expression of hippocampal synaptic genes and proteins in rats. Hippocampus 2010, 21. 10.1002/hipo.20825.
9. Bjork K., Saarikoski S.T., Arlinde C., Kovanen L., Osei-Hyiaman D., Ubaldi M., Reimers M., Hyytia P., Heilig M., Sommer W.H. Glutathione-S-transferase expression in the brain: possible role in ethanol preference and longevity. FASEB J. 2006, 20(11):1826-1835.
10. Bouchard M.F., Bellinger D.C., Weuve J., Matthews-Bellinger J., Gilman S.E., Wright R.O., Schwartz J., Weisskopf M.G. Blood lead levels and major depressive disorder, panic disorder, and generalized anxiety disorder in us young adults. Arch. Gen. Psychiatry 2009, 66(12):1313-1319.
11. Cecil K.M., Brubaker C.J., Adler C.M., Dietrich K.N., Altaye M., Egelhoff J.C., Wessel S., Elangovan I., Hornung R., Jarvis K., Lanphear B.P. Decreased brain volume in adults with childhood lead exposure. PLoS Med. 2008, 5(5):e112.
12. Chen T., Wu X.D., Gao J., Hao W., Yin B., Qiang B.Q., Yuan J.G., Gong Y.H., Peng X.Z. Role of cell adhesion molecules Necl1 in synaptogenesis in primary cultured rat neurons. Acta Acad. Med. Sin. 2008, 30(3):275-279.
13. Chiodo L.M., Jacobson S.W., Jacobson J.L. Neurodevelopmental effects of postnatal lead exposure at very low levels. Neurotoxicol. Teratol. 2004, 26(3):359-371.
14. Cory-Slechta D.A., Virgolini M.B., Thiruchelvam M., Weston D.D., Bauter M.R. Maternal stress modulates the effects of developmental lead exposure. Environ. Health Perspect. 2004, 112(6):717-730.
15. Costa L.G., Li W.F., Richter R.J., Shih D.M., Lusis A., Furlong C.E. The role of paraoxonase (Pon1) in the detoxication of organophosphates and its human polymorphism. Chem. Biol. Interact. 1999, 119-120:429-438.
16. Cox T.F., Cox M.A.A. Multidimensional Scaling 2001, Chapman and Hall, Boca Raton, FL.
17. Coyle J.T. Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell. Mol. Neurobiol. 2006, 26(4-6):365-384.
18. de Souza Lisboa S.F., Goncalves G., Komatsu F., Salci Queiroz C.A., Aparecido Almeida A.A., Gastaldello Moreira E. Developmental lead exposure induces depressive-like behavior in female rats. Drug Chem. Toxicol. 2005, 28(1):67-77.
19. Deary I.J., Harris S.E., Fox H.C., Hayward C., Wright A.F., Starr J.M., Whalley L.J. Klotho genotype and cognitive ability in childhood and old age in the same individuals. Neurosci. Lett. 2005, 378(1):22-27.
20. Dietrich K.N., Krafft K.M., Bornschein R.L., Hammond P.B., Berger O., Succop P.A., Bier M. Low-level fetal lead exposure effect on neurobehavioral development in early infancy. Pediatrics 1987, 80(5):721-730.
21. Finkelstein Y., Markowitz M.E., Rosen J.F. Low-level lead-induced neurotoxicity in children: an update on central nervous system effects. Brain Res. Rev. 1998, 27(2):168-176.
22. Freiberger J., Coulombe K., Suliman H., Carraway M., Piantadosi C. Superoxide dismutase responds to hyperoxia in rat hippocampus. Undersea Hyperb. Med. 2004, 31(2):227-232.
23. Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S., Ellis B., Gautier L., Ge Y., Gentry J., Hornik K., Hothorn T., Huber W., Iacus S., Irizarry R., Leisch F., Li C., Maechler M., Rossini A.J., Sawitzki G., Smith C., Smyth G., Tierney L., Yang J.Y., Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004, 5(10):R80.
24. Gomez Ravetti M., Rosso O.A., Berretta R., Moscato P. Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease. PLoS One 2010, 5(4):e10153.
25. Guilarte T.R. Pb2+ inhibits NMDA receptor function at high and low affinity sites: developmental and regional brain expression. Neurotoxicology 1997, 18(1):43-51.
26. Guilarte T.R. Prenatal lead exposure and schizophrenia: a plausible neurobiologic connection. Environ. Health Perspect. 2004, 112(13):A724.
27. Guilarte T.R., McGlothan J.L. Hippocampal NMDA receptor mRNA undergoes subunit specific changes during developmental lead exposure. Brain Res. 1998, 790(1-2):98-107.
28. Hagg T., Portera-Cailliau C., Jucker M., Engvall E. Laminins of the adult mammalian CNS; laminin-alpha2 (merosin M-) chain immunoreactivity is associated with neuronal processes. Brain Res. 1997, 764(1-2):17-27.
29. Haselbacher G., Groscurth P., Otten U., Vedder H., Lutz U., Sonderegger P., Bulatko A., Greeff N., Humbel R. Long-term cultivation of cryopreserved human fetal brain cells in a chemically defined medium. J. Neurosci. Methods 1989, 30(2):121-131.
30. Hashimoto K., Fukushima T., Shimizu E., Komatsu N., Watanabe H., Shinoda N., Nakazato M., Kumakiri C., Okada S., Hasegawa H., Imai K., Iyo M. Decreased serum levels of d-serine in patients with schizophrenia: evidence in support of the N-methyl-d-aspartate receptor hypofunction hypothesis of schizophrenia. Arch. Gen. Psychiatry 2003, 60(6):572-576.
31. αδ- deficient mice show earlier age-related cognitive deficits than males. Neuroscience 2007, 150(2):260-272.
32. Hodes G.E., Yang L., Van Kooy J., Santollo J., Shors T.J. Prozac during puberty: distinctive effects on neurogenesis as a function of age and sex. Neuroscience 2009, 163:609-617.
33. Hoshino M., Qi M.L., Yoshimura N., Miyashita T., Tagawa K., Wada Y., Enokido Y., Marubuchi S., Harjes P., Arai N., Oyanagi K., Blandino G., Sudol M., Rich T., Kanazawa I., Wanker E.E., Saitoe M., Okazawa H. Transcriptional repression induces a slowly progressive atypical neuronal death associated with changes of YAP isoforms and P73. J. Cell Biol. 2006, 172(4):589-604.
34. Hossain M.A., Fielding K.E., Trescher W.H., Ho T., Wilson M.A., Laterra J. Human Fgf-1 gene delivery protects against quinolinate-induced striatal and hippocampal injury in neonatal rats. Eur. J. Neurosci. 1998, 10(8):2490-2499.
35. Howe E., Holton K., Nair S., Schlauch D., Sinha R., Quankenbush J. Mev: multiexperiment viewer. Biomed. Inform. Cancer Res. 2010, 267-277.
36. Huang D.W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using David bioinformatics resources. Nat. Protoc. 2009, 4(1):44-57.
37. Irizarry R.A., Hobbs B., Collin F., Beazer-Barclay Y.D., Antonellis K.J., Scherf U., Speed T.P. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4(2):249-264.
38. Ising M., Holsboer F. Genetics of stress response and stress-related disorders. Dialogues Clin. Neurosci. 2006, 8(4):433-444.
39. Jedrychowski W., Perera F.P., Jankowski J., Mrozek-Budzyn D., Mroz E., Flak E., Edwards S., Skarupa A., Lisowska-Miszczyk I. Very low prenatal exposure to lead and mental development of children in infancy and early childhood: Krakow prospective cohort study. Neuroepidemiology 2009, 32(4):270-278.
40. Jett D.A., Kuhlmann A.C., Farmer S.J., Guilarte T.R. Age-dependent effects of developmental lead exposure on performance in the Morris water maze. Pharmacol. Biochem. Behav. 1997, 57(1-2):271-279.
41. Kim Y.B., Ryu J.K., Lee H.J., Lim I.J., Park D., Lee M.C., Kim S.U. Midkine, heparin-binding growth factor, blocks kainic acid-induced seizure and neuronal cell death in mouse hippocampus. BMC Neurosci. 2010, 11:42.
42. Knight T.R., Choudhuri S., Klaassen C.D. Constitutive mRNA expression of various glutathione S-transferase isoforms in different tissues of mice. Toxicol. Sci. 2007, 100(2):513-524.
43. Knutson M.D. Steap proteins: implications for iron and copper metabolism. Nutr. Rev. 2007, 65(7):335-340.
44. Koerner I.P., Jacks R., DeBarber A.E., Koop D., Mao P., Grant D.F., Alkayed N.J. Polymorphisms in the human soluble epoxide hydrolase gene Ephx2 linked to neuronal survival after ischemic injury. J. Neurosci. 2007, 27(17):4642-4649.
45. Koller K., Brown T., Spurgeon A., Levy L. Recent developments in low-level lead exposure and intellectual impairment in children. Environ. Health Perspect. 2004, 112(9):987-994.
46. Konishi Y., Takahashi K., Chui D.H., Rosenfeld R.G., Himeno M., Tabira T. Insulin-like growth factor ii promotes in vitro cholinergic development of mouse septal neurons: comparison with the effects of insulin-like growth factor I. Brain Res. 1994, 649(1-2):53-61.
47. Konradi C., Heckers S. Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Pharmacol. Ther. 2003, 97(2):153-179.
48. Labrie V., Fukumura R., Rastogi A., Fick L.J., Wang W., Boutros P.C., Kennedy J.L., Semeralul M.O., Lee F.H., Baker G.B., Belsham D.D., Barger S.W., Gondo Y., Wong A.H., Roder J.C. Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model. Hum. Mol. Genet. 2009, 18(17):3227-3243.
49. Lanphear B.P., Dietrich K., Auinger P., Cox C. Cognitive deficits associated with blood lead concentrations <10microg/dl in US children and adolescents. Public Health Rep. 2000, 115(6):521-529.
50. Leasure J.L., Giddabasappa A., Chaney S., Johnson J.E., Pothakos K., Lau Y.S., Fox D.A. Low-level human equivalent gestational lead exposure produces sex-specific motor and coordination abnormalities and late-onset obesity in year-old mice. Environ. Health Perspect. 2008, 116:355-361.
51. Lidsky T.I., Schneider J.S. Neuropsychological Sequelae of Pediatric Lead Exposure: Is There a Behavioral Signature? 2000, Society for Neuroscience, Washington DC.
52. Liebner S., Corada M., Bangsow T., Babbage J., Taddei A., Czupalla C.J., Reis M., Felici A., Wolburg H., Fruttiger M., Taketo M.M., von Melchner H., Plate K.H., Gerhardt H., Dejana E. Wnt/beta-catenin signaling controls development of the blood-brain barrier. J. Cell Biol. 2008, 183(3):409-417.
53. Lin Y., Ter Horst G.J., Wichmann R., Bakker P., Liu A., Li X., Westenbroek C. Sex differences in the effects of acute and chronic stress and recovery after long-term stress on stress-related brain regions of rats. Cereb. Cortex 2009, 19(9):1978-1989.
54. Madeira C., Freitas M.E., Vargas-Lopes C., Wolosker H., Panizzutti R. Increased brain d-amino acid oxidase (DAAO) activity in schizophrenia. Schizophr. Res. 2008, 101(1-3):76-83.
55. Mak G.K., Enwere E.K., Gregg C., Pakarainen T., Poutanen M., Huhtaniemi I., Weiss S. Male pheromone-stimulated neurogenesis in the adult female brain: possible role in mating behavior. Nat. Neurosci. 2007, 10(8):1003-1011.
56. Malaterre J., Ramsay R.G., Mantamadiotis T. WNT-frizzled signaling and the many paths to neural development and adult brain homeostasis. Front. Biosci. 2007, 12(2):492-506.
57. McMichael A.J., Baghurst P.A., Vimpani G.V., Robertson E.F., Wigg N.R., Tong S.L. Sociodemographic factors modifying the effect of environmental lead on neuropsychological development in early childhood. Neurotoxicol. Teratol. 1992, 14(5):321-327.
58. Meier S., Brauer A.U., Heimrich B., Schwab M.E., Nitsch R., Savaskan N.E. Molecular analysis of Nogo expression in the hippocampus during development and following lesion and seizure. FASEB J. 2003, 17(9):1153-1155.
59. Miquelajauregui A., Van de Putte T., Polyakov A., Nityanandam A., Boppana S., Seuntjens E., Karabinos A., Higashi Y., Huylebroeck D., Tarabykin V. Smad-interacting protein-1 (Zfhx1b) acts upstream of Wnt signaling in the mouse hippocampus and controls its formation. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(31):12919-12924.
60. Mizoguchi H., Ibi D., Takuma K., Toth E., Sato J., Itohara S., Nabeshima T., Yamada K. Alterations of emotional and cognitive behaviors in matrix metalloproteinase-2 and -9 deficient mice. Open Behav. Sci. J. 2010, 4:19-25.
61. Mocchegiani E., Malavolta M. Zinc dyshomeostasis, ageing and neurodegeneration: implications of A2m and inflammatory gene polymorphisms. J. Alzheimers Dis. 2007, 12(1):101-109.
62. Mocchetti I., Bachis A., Masliah E. Chemokine receptors and neurotrophic factors: potential therapy against AIDS dementia?. J. Neurosci. Res. 2008, 86(2):243-255.
63. Moreira E.G., Vassilieff I., Vassilieff V.S. Developmental lead exposure: behavioral alterations in the short and long term. Neurotoxicol. Teratol. 2001, 23(5):489-495.
64. Nakamura E., Kadomatsu K., Yuasa S., Muramatsu H., Mamiya T., Nabeshima T., Fan Q.W., Ishiguro K., Igakura T., Matsubara S., Kaname T., Horiba M., Saito H., Muramatsu T. Disruption of the midkine gene (Mdk) resulted in altered expression of a calcium binding protein in the hippocampus of infant mice and their abnormal behaviour. Genes Cells 1998, 3(12):811-822.
65. Ngun T.C., Ghahramani N., Sanchez F.J., Bocklandt S., Vilain E. The genetics of sex differences in brain and behavior. Front. Neuroendocrinol. 2011, 32(2):227-246.
66. Nihei M.K., Guilarte T.R. Nmdar-2a subunit protein expression is reduced in the hippocampus of rats exposed to Pb2+ during development. Mol. Brain Res. 1999, 66(1-2):42-49.
67. Opler M.G., Brown A.S., Graziano J., Desai M., Zheng W., Schaefer C., Factor-Litvak P., Susser E.S. Prenatal lead exposure, delta-aminolevulinic acid, and schizophrenia. Environ. Health Perspect. 2004, 112(5):548-552.
68. Opler M.G., Buka S.L., Groeger J., McKeague I., Wei C., Factor-Litvak P., Bresnahan M., Graziano J., Goldstein J.M., Seidman L.J., Brown A.S., Susser E.S. Prenatal exposure to lead, delta-aminolevulinic acid, and schizophrenia: further evidence. Environ. Health Perspect. 2008, 116(11):1586-1590.
69. Orabona G.M., Griesi-Oliveira K., Vadasz E., Bulcao V.L., Takahashi V.N., Moreira E.S., Furia-Silva M., Ros-Melo A.M., Dourado F., Matioli S.R., Otto P., Passos-Bueno M.R. Htr1b and Htr2c in autism spectrum disorders in Brazilian families. Brain Res. 2009, 1250:14-19.
70. Paschen W., Linden T., Doutheil J. Effects of transient cerebral ischemia on Hsp40 mRNA levels in rat brain. Mol. Brain Res. 1998, 55(2):341-344.
71. Pueschel S.M., Linakis J.G., Anderson A.C. Lead poisoning: a historical perspective. Lead Poisoning in Childhood 1996, 1-13. P.H. Brooks Publishing, Baltimore, MD. S.M. Pueschel, J.G. Linakis, A.C. Anderson (Eds.).
72. Rabinowitz M.B., Wang J.D., Soong W.T. Dentine lead and child intelligence in Taiwan. Arch. Environ. Health 1991, 46(6):351-360.
73. Reynolds C.A., Gatz M., Berg S., Pedersen N.L. Genotype-environment interactions: cognitive aging and social factors. Twin Res. Hum. Genet. 2007, 10(2):214-254.
74. Roberts L.M., Woodford K., Zhou M., Black D.S., Haggerty J.E., Tate E.H., Grindstaff K.K., Mengesha W., Raman C., Zerangue N. Expression of the thyroid hormone transporters monocarboxylate transporter-8 (Slc16a2) and organic ion transporter-14 (Slco1c1) at the blood-brain barrier. Endocrinology 2008, 149(12):6251-6261.
75. Shibasaki K., Suzuki M., Mizuno A., Tominaga M. Effects of body temperature on neural activity in the hippocampus: regulation of resting membrane potentials by transient receptor potential vanilloid 4. J. Neurosci. 2007, 27(7):1566-1575.
76. Silva A.J., Kogan J.H., Frankland P.W., Kida S. Creb and memory. Annu. Rev. Neurosci. 1998, 21:127-148.
77. Sirri A., Bianchi V., Pelizzola M., Mayhaus M., Ricciardi-Castagnoli P., Toniolo D., D'Adamo P. Temporal gene expression profile of the hippocampus following trace fear conditioning. Brain Res. 2010, 1308:14-23.
78. Sleegers K., den Heijer T., van Dijk E.J., Hofman A., Bertoli-Avella A.M., Koudstaal P.J., Breteler M.M., van Duijn C.M. Ace gene is associated with Alzheimer's disease and atrophy of hippocampus and amygdala. Neurobiol. Aging 2005, 26(8):1153-1159.
79. Soeiro A.C., Gouvea T.S., Moreira E.G. Behavioral effects induced by subchronic exposure to Pb and their reversion are concentration and gender dependent. Hum. Exp. Toxicol. 2007, 26(9):733-739.
80. Storey J.D., Tibshirani R. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. U. S. A. 2003, 100(16):9440-9445.
81. Szklarczyk A., Lapinska J., Rylski M., McKay R.D., Kaczmarek L. Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. J. Neurosci. 2002, 22(3):920-930.
82. Tong S., McMichael A.J., Baghurst P.A. Interactions between environmental lead exposure and sociodemographic factors on cognitive development. Arch. Environ. Health 2000, 55(5):330-335.
83. Torbati D., Totapally B.R., Raszynski A., Osborne J., Zyl L., Kalomiris S., Wolfsdorf J. Age and sex differences in brain gene expression in neonatal rats. Neuropediatrics 2008, 39(4):219-225.
84. Toscano C.D., Guilarte T.R. Lead neurotoxicity: from exposure to molecular effects. Brain Res. Rev. 2005, 49(3):529-554.
85. Tsai G., Coyle J.T. Glutamatergic mechanisms in schizophrenia. Annu. Rev. Pharmacol. Toxicol. 2002, 42:165-179.
86. Ye P., Carson J., D'Ercole A.J. In vivo actions of insulin-like growth factor-I (Igf-I) on brain myelination: studies of Igf-I and Igf binding protein-1 (Igfbp-1) transgenic mice. J. Neurosci. 1995, 15(11):7344-7356.
87. Ye P., Carson J., D'Ercole A.J. Insulin-like growth factor-I influences the initiation of myelination: studies of the anterior commissure of transgenic mice. Neurosci. Lett. 1995, 201(3):235-238.
88. Zhang X.Y., Liu A.P., Ruan D.Y., Liu J. Effect of developmental lead exposure on the expression of specific NMDA receptor subunit mRNAs in the hippocampus of neonatal rats by digoxigenin-labeled in situ hybridization histochemistry. Neurotoxicol. Teratol. 2002, 24(2):149-160.